Radian Group Inc. RDN

Zacks Investment Research 11 nov

A comparison of two insurance stocks in the multi-line sector shows Radian (RDN) presents a better value opportunity than Axa Sa (AXAHY). Radian has a Zacks Rank of #2 (Buy) with stronger valuation metrics including a lower forward P/E ratio of 7.49 versus 11.25, a PEG ratio of 0.93 versus 5.28, and a Value grade of A compared to C. Axa Sa carries a Zacks Rank of #4 (Sell).

Zacks Investment Research 5 nov

Radian Group reported Q3 2026 adjusted operating income of $1.44 per share, beating consensus by 13.4%, with revenues surging 105.9% to $624.1M driven by the Inigo acquisition. Specialty Insurance showed strong performance with an improved 80.4% combined ratio, while the Mortgage segment faced headwinds from elevated defaults and declining new insurance written. The company maintained capital deployment through share repurchases and dividends while advancing its business simplification strategy.

Zacks Investment Research 4 nov

Radian (RDN) reported Q3 2026 earnings of $1.44 per share, beating consensus estimates of $1.27 by 13.39%, but missed revenue expectations with $628.14 million versus the estimated $641.2 million. The stock received a Zacks Rank #3 (Hold) rating and has underperformed the S&P 500 by 11% year-to-date. The Insurance - Multi line industry ranks in the bottom 37% of Zacks industries.

Zacks Investment Research 3 nov

Prudential reported Q3 2026 earnings of $3.77 per share, beating consensus estimates of $3.31 by 13.90%, but revenues of $13.49 billion missed expectations by 3.35%. Despite the earnings beat, the company received a Zacks Rank #4 (Sell) rating due to unfavorable estimate revision trends. The stock has underperformed the S&P 500 year-to-date, gaining 4.8% versus the market's 10.2% gain.

Zacks Investment Research 15 oct

A comparison of two insurance stocks reveals that Radian (RDN) presents a superior value opportunity compared to Allianz SE (ALIZY). RDN holds a Zacks Rank #2 (Buy) with stronger earnings outlook improvements, lower valuation multiples (forward P/E of 6.85 vs 13.48), and a Value grade of A versus ALIZY's C grade.